Header Logo

Connection

Kritisha Bhandari to Pancreatic Neoplasms

This is a "connection" page, showing publications Kritisha Bhandari has written about Pancreatic Neoplasms.
Connection Strength

1.572
  1. The Level of a Short Form of Multidrug Resistance-Associated Protein 1 Is Elevated in Plasma Small Extracellular Vesicles Derived From Patients With Pancreatic Ductal Adenocarcinoma. FASEB J. 2025 Jul 31; 39(14):e70849.
    View in: PubMed
    Score: 0.624
  2. Protein Arginine Methyltransferases in Pancreatic Ductal Adenocarcinoma: New Molecular Targets for Therapy. Int J Mol Sci. 2024 Apr 02; 25(7).
    View in: PubMed
    Score: 0.569
  3. miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma. Int J Mol Sci. 2023 Apr 13; 24(8).
    View in: PubMed
    Score: 0.133
  4. Pancreatic Ductal Cell-Derived Extracellular Vesicles Are Effective Drug Carriers to Enhance Paclitaxel's Efficacy in Pancreatic Cancer Cells through Clathrin-Mediated Endocytosis. Int J Mol Sci. 2022 Apr 26; 23(9).
    View in: PubMed
    Score: 0.124
  5. Isolation of extra-cellular vesicles in the context of pancreatic adenocarcinomas: Addition of one stringent filtration step improves recovery of specific microRNAs. PLoS One. 2021; 16(11):e0259563.
    View in: PubMed
    Score: 0.121
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.